About Cynerio
Cynerio is a company based in New York (United States) founded in 2017 by Leon Lerman and Daniel Brodie was acquired by Axonius in July 2025. Cynerio has raised $37 million across 3 funding rounds from investors including Axonius, Elron Ventures and Motion Technology, Inc. Cynerio offers products and services including Healthcare Cybersecurity Platform, Network Detection and Response, Complete Asset Visibility, and Medical Device Security. Cynerio operates in a competitive market with competitors including Intraprise Health, Cylera, Medigate, MDClone and Censinet, among others.
- Headquarter New York, United States
- Founders Leon Lerman, Daniel Brodie
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cynerio
Cynerio offers a comprehensive portfolio of products and services, including Healthcare Cybersecurity Platform, Network Detection and Response, Complete Asset Visibility, and Medical Device Security.
Integrated system for detecting and mitigating cyber threats in healthcare.
Proactive tool to identify and respond to network attacks in healthcare.
Automates discovery and analysis of connected devices for security.
Provides protections and insights for healthcare technology against risks.
People of Cynerio
Unlock access to complete
Unlock access to complete
Funding Insights of Cynerio
Cynerio has successfully raised a total of $37M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cynerio
Cynerio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Axonius, Elron Ventures and Motion Technology, Inc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund focused on digital health and digital medical device companies
|
Locked | Locked | Locked |
Investor details for Cynerio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cynerio
Investment portfolio details for Cynerio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cynerio
Detailed financials for Cynerio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cynerio Comparisons
Peer comparison for Cynerio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cynerio
Cynerio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intraprise Health, Cylera, Medigate, MDClone and Censinet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient engagement and care coordination solution for healthcare providers
|
|
| Locked | Locked | Locked |
SaaS-based IoT security platform for healthcare is provided.
|
|
| Locked | Locked | Locked |
Medical device security is delivered via cloud and IoT monitoring.
|
|
| Locked | Locked | Locked |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| Locked | Locked | Locked |
Cloud-based risk and vendor management solutions for healthcare are provided.
|
|
| Locked | Locked | Locked |
AI and cloud-based platform developed for healthcare data protection.
|
Detailed competitors of Cynerio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cynerio
Complete news archive for Cynerio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cynerio
Cynerio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Cynerio is headquartered in New York, United States. It is registered at New York, New York, United States.
Leon Lerman is the current CEO of Cynerio. They have also founded this company.
Cynerio is a funded company, having raised a total of $37M across 3 funding rounds to date.
Cynerio was founded in 2017 and is headquartered in New York, United States. Operations focus on the healthcare cybersecurity sector, where a network-based platform is utilized to offer visibility into medical device functions and behaviors. Connected devices are continuously discovered and classified, with network communications mapped based on context. Threats are detected through healthcare-specific behavior analysis, ensuring operational availability and patient safety.
Cynerio's top competitors include Intraprise Health, Censinet and Medigate.
Cynerio offers Healthcare Cybersecurity Platform, Network Detection and Response, Complete Asset Visibility, and Medical Device Security.
Cynerio has 8 investors. Key investors include Axonius, Elron Ventures, Motion Technology, Inc, ALIVE, and Accelmed.